TROY HALTEMAN: Open Payments
NPI 1689226573 · MONROEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 65 payments from 14 companies in 2025. Trend: 2023 $429 · 2024 $372 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $195 |
| Novartis Pharmaceuticals Corporation | 15 | $179 |
| PFIZER INC. | 5 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $110 |
| HEARTFLOW, INC. | 6 | $99 |
| SCPHARMACEUTICALS INC. | 4 | $65 |
| Novo Nordisk Inc | 3 | $61 |
| Edwards Lifesciences Corporation | 1 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $39 |
Products named: REPATHA, LEQVIO, JARDIANCE, Kerendia, FFRct, VYNDAQEL, FUROSCIX, ELIQUIS.
Industry payments across PA — which companies pay providers there.
